mHealth: LabStyle's diabetes management device and mobile app lands E.U. approval

Mon, 09/23/2013 - 12:26pm
Mass Device

Israeli device maker LabStyle Innovations gains 4% on Wall Street today after announcing plans for "soft launch" of its Dario smartphone-based diabetes management system.

Smartphone diabetes management tool Dario lands E.U. approval

Two-year-old LabStyle Innovations Corp. (OTCQB:DRIO) made the shift from an R&D-stage company to a commercial enterprise with CE Mark approval in the European Union to market its smartphone diabetes management system, the Dario all-inclusive blood glucose monitoring device and mobile data management system.

The mobile app is also a stand-alone program that LabStyle plans to offer to users of other glucose monitors, according to a company statement. The device maker is also hoping to accelerate its FDA 510(k) submission efforts, after which LabStyle will focus on regulatory submissions in Asia and South America.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.